Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Nature|May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltratesYannick Simoni, Etienne Becht, Michael Fehlings, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Immunity|December 18, 2016
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and FrequencyYannick Simoni, Michael Fehlings, Henrik N Kløverpris, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerGillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesKhi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Nature Genetics|February 5, 2020
Genomic landscape of lung adenocarcinoma in East AsiansJianbin Chen, Hechuan Yang, Audrey Su Min Teo, et al.
Nature Medicine|March 20, 2012
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerKing Pan Ng, Axel M Hillmer, Charles T H Chuah, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Nature|May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltratesYannick Simoni, Etienne Becht, Michael Fehlings, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Immunity|December 18, 2016
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and FrequencyYannick Simoni, Michael Fehlings, Henrik N Kløverpris, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerGillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesKhi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Nature Genetics|February 5, 2020
Genomic landscape of lung adenocarcinoma in East AsiansJianbin Chen, Hechuan Yang, Audrey Su Min Teo, et al.
Nature Medicine|March 20, 2012
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerKing Pan Ng, Axel M Hillmer, Charles T H Chuah, et al.
Pageof 11